China NMPA Issues “Evaluation Standards for Cosmetics Efficacy Claims”

In order to implement the “Cosmetics Supervision and Administration Regulations (CSAR)”, The National Medical Products Administration (NMPA) issued The  “Cosmetics Efficacy Claim Evaluation Standards”  which will come into force on May 1, 2021.  The implementation-related issues are hereby announced as follows: 1. Starting from January 1, 2022, cosmetics registrants and filling persons (Cosmetics Brands) who apply for special cosmetics registration or general cosmetics filing/notification shall evaluate the efficacy claims of cosmetics in accordance with the requirements of the standard, And upload a summary of the basis for product efficacy claims on a special website designated by the NMPA. 2. For…